A splicing silencer in SMN2 intron 6 is critical in spinal muscular atrophy
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddac260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Li Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, China. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Muscular Atrophy, Spinal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Spinal muscular atrophy (SMA) is a fatal neuromuscular disease caused by homozygous deletions or mutations of the SMN1 gene. SMN2 is a paralogous gene of SMN1 and a modifying gene of SMA. A better understanding of how SMN2 exon 7 splicing is regulated helps discover new therapeutic targets for SMA therapy. Based on an antisense walk method to map exonic and intronic splicing silencers (ESSs and ISSs) in SMN2 exon 7 and the proximal regions of its flanking introns, we identified one ISS (ISS6-KH) at upstream of the branch point site in intron 6. By using mutagenesis-coupled RT-PCR with SMN1/2 minigenes, immunochromatography, overexpression and siRNA-knockdown, we found this ISS consists of a bipartite hnRNP A1 binding cis-element and a poly-U sequence located between the proximal hnRNP A1 binding site (UAGCUA) and the branch site. Both HuR and hnRNP C1 proteins promote exon 7 skipping through the poly-U stretch. Mutations or deletions of these motifs lead to efficient SMN2 exon 7 inclusion comparable to SMN1 gene. Furthermore, we identified an optimal antisense oligonucleotide that binds the intron six ISS and causes striking exon 7 inclusion in the SMN2 gene in patient fibroblasts and SMA mouse model. Our findings demonstrate that this novel ISS plays an important role in SMN2 exon 7 skipping and highlight a new therapeutic target for SMA therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, China.
- Nanjing Antisense Biopharmaceutical Co., Ltd, Nanjing 210046, China.
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Wang, L., Ji, Y., Chen, Y., Bai, J., Gao, P., & Feng, P. (2023). A splicing silencer in SMN2 intron 6 is critical in spinal muscular atrophy. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddac260
Vancouver
Wang L, Ji Y, Chen Y, Bai J, Gao P, Feng P. A splicing silencer in SMN2 intron 6 is critical in spinal muscular atrophy. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddac260
BibTeX
@article{Wang2023,
author = {Wang, Li and Ji, Yinfeng and Chen, Yuqing and Bai, Jialin and Gao, Peng and Feng, Pengchao},
title = {A splicing silencer in SMN2 intron 6 is critical in spinal muscular atrophy},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddac260}
}
EUVIMED